Home/Filings/4/0001062993-24-004684
4//SEC Filing

Yi Sang 4

Accession 0001062993-24-004684

CIK 0001136869other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 8:55 PM ET

Size

7.5 KB

Accession

0001062993-24-004684

Insider Transaction Report

Form 4
Period: 2024-02-25
Yi Sang
Group President, Asia Pacific
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2024-02-255,0470 total
    From: 2024-02-25Exp: 2024-02-25Common Stock (5,047 underlying)
  • Exercise/Conversion

    Common Stock

    2024-02-25+5,04713,762 total
Footnotes (3)
  • [F1]This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.
  • [F2]Includes 188 shares acquired under the Company's Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 1, 2024.
  • [F3]Each RSU represents a contingent right to receive one share of Company common stock.

Issuer

ZIMMER BIOMET HOLDINGS, INC.

CIK 0001136869

Entity typeother

Related Parties

1
  • filerCIK 0001635943

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 8:55 PM ET
Size
7.5 KB